AR078082A1 - Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionados - Google Patents
Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionadosInfo
- Publication number
- AR078082A1 AR078082A1 ARP100102706A ARP100102706A AR078082A1 AR 078082 A1 AR078082 A1 AR 078082A1 AR P100102706 A ARP100102706 A AR P100102706A AR P100102706 A ARP100102706 A AR P100102706A AR 078082 A1 AR078082 A1 AR 078082A1
- Authority
- AR
- Argentina
- Prior art keywords
- mol
- methods
- pharmaceutical compositions
- include modified
- related kits
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones y métodos con relacion a agentes de fucanos utiles para el tratamiento, prevencion, inhibicion, etc., de adhesiones fibrosas u otras enfermedades. Reivindicacion 1: Una composicion médica caracterizada porque comprende una cantidad terapéuticamente efectiva de un fucano en combinacion con por lo menos un excipiente, relleno, portador. o diluyente farmacéuticamente aceptables, en donde el fucano tiene un contenido de sulfato comprendido entre alrededor de 14 y 40% p/p; un contenido total de carbohidratos comprendido entre alrededor de 37 y 75% p/p; una distribucion de peso molecular tal que la porcion de alrededor de 0 a 5.000 g/mol está comprendida entre alrededor de 0 y 25% p/p, la porcion de alrededor de 5.000 a 60.000 g/mol está comprendida entre alrededor de 5 y 38% p/p, la porcion de alrededor de 60.000 a 200.000 g/mol está comprendida entre alrededor de 10 y 30% p/p, la porcion de alrededor de 200.000 a 1.600.000 g/mol está comprendida entre alrededor de 8 y 43% p/p, y la porcion de más de alrededor de 1.600.000 g/mol está comprendida entre alrededor de 1 y 33% p/p.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22892909P | 2009-07-27 | 2009-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR078082A1 true AR078082A1 (es) | 2011-10-12 |
Family
ID=43497856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100102706A AR078082A1 (es) | 2009-07-27 | 2010-07-27 | Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionados |
Country Status (19)
| Country | Link |
|---|---|
| US (6) | US8466125B2 (es) |
| EP (2) | EP3300737A1 (es) |
| JP (5) | JP2013500274A (es) |
| KR (1) | KR20120083297A (es) |
| CN (2) | CN106176798A (es) |
| AR (1) | AR078082A1 (es) |
| AU (4) | AU2010278640A1 (es) |
| BR (1) | BR112012008072A2 (es) |
| CA (2) | CA3046665C (es) |
| CL (1) | CL2012000215A1 (es) |
| EA (1) | EA201270186A1 (es) |
| IN (1) | IN2012DN01314A (es) |
| JO (1) | JO3676B1 (es) |
| MX (1) | MX2012001212A (es) |
| MY (1) | MY168759A (es) |
| SG (3) | SG10201401436VA (es) |
| TW (2) | TWI491396B (es) |
| WO (1) | WO2011011881A1 (es) |
| ZA (1) | ZA201200999B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006032144A1 (en) * | 2004-09-23 | 2006-03-30 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using fucans from various echinoderm sources |
| JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
| JP2013521300A (ja) * | 2010-03-03 | 2013-06-10 | ネオキュティス エスアー | 抗菌ペプチド隔離化合物を用いた皮膚疾患および皮膚障害の処置のための組成物および方法 |
| FR2984126B1 (fr) * | 2011-12-20 | 2014-08-22 | Oreal | Polysaccharides sulfates agent antipelliculaire |
| EP3258932B1 (en) | 2015-02-16 | 2024-08-07 | Lasserre, Gilles Henri | Composition for prevention or treatment of cutaneous disorder |
| CN105663154B (zh) * | 2016-01-18 | 2020-06-30 | 首都医科大学 | 褐藻多糖硫酸酯在制备预防和/或治疗下肢外周动脉血管病的产品中的应用 |
| US20180056087A1 (en) * | 2016-08-26 | 2018-03-01 | Adolfo Ribeiro | Wearable Micro-LED Healing Bandage |
| CN106943619A (zh) * | 2017-03-17 | 2017-07-14 | 清华大学 | 一种液体伤口敷料及其制备方法 |
| US11446326B2 (en) * | 2018-07-27 | 2022-09-20 | ARC Medical Devices | Highly sulfated fucans for the treatment of fibrous adhesions |
| CN115260328A (zh) * | 2022-08-14 | 2022-11-01 | 湘潭大学 | 一种改性岩藻多糖化合物及其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5605938A (en) * | 1991-05-31 | 1997-02-25 | Gliatech, Inc. | Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate |
| IT1288713B1 (it) * | 1996-12-18 | 1998-09-23 | Crinos Industria Farmaco | Fucani a basso peso molecolare aventi attivita' anticoagulante antitrombinica e antitrombotica |
| FR2772618B1 (fr) * | 1997-12-18 | 2000-02-18 | Ifremer | Utilisation de fucane comme regulateur de la reconstruction des tissus conjonctifs |
| CN100384433C (zh) * | 1999-08-20 | 2008-04-30 | 宝生物工程株式会社 | 治疗剂 |
| US6812220B2 (en) | 2001-08-29 | 2004-11-02 | University Of British Columbia | Pharmaceutical compositions and methods relating to fucans |
| NO320671B1 (no) * | 2001-11-30 | 2006-01-16 | Fmc Biopolymer As | Fremgangsmate for a stimulere vektokning i fisk. |
| CN1829501A (zh) | 2003-05-30 | 2006-09-06 | Arc药品有限公司 | 涉及使用多种药物抑制纤维粘连的药用组合物和方法 |
| WO2004105737A2 (en) | 2003-05-30 | 2004-12-09 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents |
| WO2006032144A1 (en) | 2004-09-23 | 2006-03-30 | Arc Pharmaceuticals, Inc. | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using fucans from various echinoderm sources |
| US8426381B2 (en) * | 2005-09-09 | 2013-04-23 | Lucas Meyer Cosmetics Canada Inc. | Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation |
| CN1935154A (zh) * | 2006-09-04 | 2007-03-28 | 北京世纪博康医药科技有限公司 | 褐藻多糖硫酸酯在制备治疗心脑血管疾病的药物中的用途 |
| JP5679663B2 (ja) * | 2007-02-23 | 2015-03-04 | バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ | 海藻抽出物からのフコイダン精製のためのプロセスの方法 |
| GB0707096D0 (en) * | 2007-04-12 | 2007-05-23 | Ntnu Technology Transfer As | Method |
| JO3676B1 (ar) * | 2009-07-27 | 2020-08-27 | Arc Medical Devices Inc | مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها |
-
2010
- 2010-07-25 JO JOP/2010/0261A patent/JO3676B1/ar active
- 2010-07-26 TW TW099124495A patent/TWI491396B/zh active
- 2010-07-26 TW TW104117619A patent/TWI569801B/zh not_active IP Right Cessation
- 2010-07-27 EP EP17193478.9A patent/EP3300737A1/en not_active Withdrawn
- 2010-07-27 CN CN201610545789.8A patent/CN106176798A/zh active Pending
- 2010-07-27 EA EA201270186A patent/EA201270186A1/ru unknown
- 2010-07-27 US US12/843,992 patent/US8466125B2/en active Active
- 2010-07-27 JP JP2012521918A patent/JP2013500274A/ja active Pending
- 2010-07-27 AU AU2010278640A patent/AU2010278640A1/en not_active Abandoned
- 2010-07-27 SG SG10201401436VA patent/SG10201401436VA/en unknown
- 2010-07-27 MX MX2012001212A patent/MX2012001212A/es active IP Right Grant
- 2010-07-27 EP EP10803778A patent/EP2459200A4/en not_active Ceased
- 2010-07-27 BR BR112012008072A patent/BR112012008072A2/pt not_active Application Discontinuation
- 2010-07-27 CA CA3046665A patent/CA3046665C/en active Active
- 2010-07-27 SG SG10201808960VA patent/SG10201808960VA/en unknown
- 2010-07-27 CA CA2769147A patent/CA2769147A1/en not_active Abandoned
- 2010-07-27 KR KR1020127004988A patent/KR20120083297A/ko not_active Application Discontinuation
- 2010-07-27 AR ARP100102706A patent/AR078082A1/es not_active Application Discontinuation
- 2010-07-27 SG SG2012005104A patent/SG177741A1/en unknown
- 2010-07-27 CN CN201080042840.4A patent/CN102665733B/zh active Active
- 2010-07-27 WO PCT/CA2010/001175 patent/WO2011011881A1/en active Application Filing
- 2010-07-27 MY MYPI2012000343A patent/MY168759A/en unknown
-
2012
- 2012-01-26 CL CL2012000215A patent/CL2012000215A1/es unknown
- 2012-02-10 ZA ZA2012/00999A patent/ZA201200999B/en unknown
- 2012-02-13 IN IN1314DEN2012 patent/IN2012DN01314A/en unknown
-
2013
- 2013-06-14 US US13/918,544 patent/US20140128340A1/en not_active Abandoned
-
2014
- 2014-05-27 US US14/287,307 patent/US20140274942A1/en not_active Abandoned
-
2016
- 2016-02-04 JP JP2016019894A patent/JP2016128491A/ja active Pending
- 2016-08-24 AU AU2016219615A patent/AU2016219615A1/en not_active Abandoned
- 2016-09-22 US US15/272,949 patent/US20180051097A1/en not_active Abandoned
-
2017
- 2017-07-03 JP JP2017130195A patent/JP2017206542A/ja active Pending
- 2017-09-27 US US15/717,681 patent/US20180230240A1/en not_active Abandoned
-
2018
- 2018-05-16 AU AU2018203461A patent/AU2018203461A1/en not_active Abandoned
-
2019
- 2019-04-03 JP JP2019071611A patent/JP2019142896A/ja active Pending
- 2019-05-17 US US16/415,397 patent/US20200115472A1/en not_active Abandoned
- 2019-11-20 AU AU2019268096A patent/AU2019268096A1/en not_active Abandoned
-
2020
- 2020-09-30 JP JP2020164770A patent/JP2021020907A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR078082A1 (es) | Composiciones farmaceuticas que comprenden fucanos modificados, metodos y kits relacionados | |
| AR115939A2 (es) | Composición que contiene palmitoil-etanolamida ultra-micronizada | |
| AR067495A1 (es) | Composiciones farmaceuticas y procedimientode tratamientos de trastornos de ojo seco | |
| PH12017501185A1 (en) | Compounds, compositions and methods useful for cholesterol mobilisation | |
| HK1160779A1 (en) | Cdk inhibitor for the treatment of mesothelioma | |
| WO2008092006A3 (en) | Antimicrobial compositions | |
| ECSP10010416A (es) | Forma de dosificación farmaceutica | |
| UA95310C2 (ru) | Композиция, содержащая ингибитор chk1 и циклодекстрин, для лечения рака | |
| MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
| EA201490489A1 (ru) | Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7 | |
| CR11510A (es) | Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer | |
| SG158073A1 (en) | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| ECSP13012755A (es) | Composiciones farmacéuticas que contienen un inhibidor de dgat1 | |
| HK1149717A1 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
| IN2012DN02645A (es) | ||
| WO2007112272A3 (en) | Formulations of low dose diclofenac and beta-cyclodextrin | |
| BRPI0816798A2 (pt) | composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação | |
| WO2010038237A3 (en) | Compositions exhibiting delayed transit through the gastrointestinal tract | |
| AR077138A1 (es) | Composiciones farmaceuticas utiles para tratar el vhc | |
| AR062658A1 (es) | Terapias de combinacion para artritis reumatoide | |
| GT200600157A (es) | Asociacion entre la ferroquina y un derivado de artemisinina para el tratamiento del paludismo | |
| AR077139A1 (es) | Composiciones farmaceuticas utiles para tratar el vch | |
| DOP2011000335A (es) | Combinacion antitumoral que comprende ave8062 y sorafenib | |
| BR112012022209A2 (pt) | composições farmacêuticas compreendendo monoterpenos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |